Enzolytics Inc. (ENZC)
USD 0.0
(-16.67%)
USD 0.0
(-16.67%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -880.07 Thousand | -2.66 Million | -1.3 Million | -491.01 Thousand | -2241.00 | -3.24 Million |
| Net Income | -2.17 Million | -2.94 Million | -669.48 Thousand | -3.48 Million | 920.42 Thousand | -1.75 Million |
| Depreciation & Amortization | 22.08 Thousand | 22.08 Thousand | 20.44 Thousand | 16.96 Thousand | 16.96 Thousand | 16.81 Thousand |
| Deferred income taxes | 100.6 Million | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -156.45 Thousand | 236 Thousand | -657.34 Thousand | 94.75 Thousand | 361 Thousand | -2.73 Million |
| Other non-cash items | 1.5 Million | 66.67 Thousand | 40.88 Thousand | 2.91 Million | -1.18 Million | 1.6 Million |
| Investing Cash Flow | - | - | -165.92 Thousand | - | - | 3.2 Million |
| Investments in PPE | -3.00 | - | -165.92 Thousand | - | - | - |
| Acquisitions | - | - | - | - | - | 3.2 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 340.59 Thousand | 932.81 Thousand | 3.19 Million | 1.85 Million | 4190.00 | 43.15 Thousand |
| Debt repayment | -809.63 Thousand | -67.18 Thousand | -243.97 Thousand | -239.26 Thousand | -2500.00 | -26.52 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 38.38 Thousand | 1 Million | 2.95 Million | 1.61 Million | - | 12.5 Thousand |
| Other Financing Activities | -507.43 Thousand | - | 100.00 | 5050.00 | 6690.00 | 4134.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -32.14 Thousand | - | - | - | -85.02 Thousand | -340.19 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -124.31 Thousand | 236 Thousand | -657.34 Thousand | 94.75 Thousand | 361 Thousand | -2.39 Million |
| Cash at beginning of period | 554.16 Thousand | 2.28 Million | 560.38 Thousand | 2091.00 | 142.00 | 132.00 |
| Cash at end of period | 14.68 Thousand | 554.16 Thousand | 2.28 Million | 560.38 Thousand | 2091.00 | 142.00 |
| Capital Expenditure | -3.00 | - | -165.92 Thousand | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -539.48 Thousand | -1.72 Million | 1.72 Million | 558.29 Thousand | 1949.00 | 10.00 |
| Free Cash Flow | -880.08 Thousand | -2.66 Million | -1.47 Million | -491.01 Thousand | -2241.00 | -3.24 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1818.00 | -172.75 Thousand | -2.17 Million | -2.27 Million | -1.21 Million | -427.55 Thousand |
| Depreciation & Amortization | 5522.00 | 5522.00 | 22.08 Thousand | 11.04 Thousand | 5522.00 | 5522.00 |
| Deferred income taxes | - | - | 100.6 Million | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 114.77 Million | 136.98 Thousand | -156.45 Thousand | 563.49 Thousand | 99.33 Thousand | 24.42 Thousand |
| Other non-cash items | 68.04 Thousand | 6147.00 | 1.5 Million | 2.73 Million | -111.55 Thousand | 19.53 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | 1.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 499.5 Thousand | 10 Thousand | 340.59 Thousand | -1.16 Million | 1.72 Million | - |
| Debt repayment | -10 Thousand | -10 Thousand | -809.63 Thousand | -440.52 Thousand | -1 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 509.5 Thousand | - | 38.38 Thousand | -721.38 Thousand | 721.38 Thousand | - |
| Other Financing Activities | - | - | -507.43 Thousand | - | 1.00 | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | 12.39 Thousand | -32.14 Thousand | -59.22 Thousand | 122.59 Thousand | -8487.00 |
| Inventory | - | - | - | - | - | - |
| Other working capital | 159.45 Million | 124.58 Thousand | -124.31 Thousand | 668.07 Thousand | -23.25 Thousand | 32.91 Thousand |
| Cash at beginning of period | 1928.00 | 559.55 Thousand | 554.16 Thousand | 765.03 Thousand | 156.55 Thousand | 554.16 Thousand |
| Cash at end of period | 115.34 Million | 1928.00 | 14.68 Thousand | 559.55 Thousand | 765.03 Thousand | 156.55 Thousand |
| Capital Expenditure | 1.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 115.34 Million | -557.62 Thousand | -539.48 Thousand | -205.47 Thousand | 608.47 Thousand | -397.61 Thousand |
| Free Cash Flow | 114.84 Million | -22.75 Thousand | -880.07 Thousand | 956.42 Thousand | -1.11 Million | -397.61 Thousand |
BDX
BHAGCHEM
0KTS
000676
NHPC
NILKAMAL